Clinical Trial Update: Single Dose Study of BMS-820836 [Phase 1]

View source ↗

Summary

The document reports the completion of a single-dose Phase 1 study of the investigational antidepressant BMS-820836.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• BMS-820836

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Depression | Phase 1 | Status: COMPLETED